VSee Health, Inc. Increase (Decrease) in Contract with Customer, Liability
VSee Health, Inc. (VSEE) reported Increase (Decrease) in Contract with Customer, Liability of $836.67 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-03-31
- VSee Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $174.39K.
- VSee Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$20.01K.
- VSee Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $323.43K.
- VSee Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $358.86K, a 23.48% decline year-over-year.
- VSee Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was $836.67K.
- VSee Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$414.71K.
- VSee Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$104.04K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $174.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $154.38K derived: sum of 2 quarters · filed 2026-03-31 | $477.81K derived: sum of 3 quarters · filed 2026-03-31 | $836.67K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$20.01K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | $303.42K derived: sum of 2 quarters · filed 2025-11-20 | $662.28K 10-Q · filed 2025-11-14 | $466.98K derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2025-06-30 | $323.43K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | $682.29K 10-Q/A · filed 2025-11-20 | $486.99K derived: sum of 3 quarters · filed 2026-03-31 | $146.61K derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2025-03-31 | $358.86K 10-Q · filed 2025-10-15 | $163.56K derived: sum of 2 quarters · filed 2026-03-31 | -$176.82K derived: sum of 3 quarters · filed 2026-03-31 | -$524.85K derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-12-31 | -$195.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$535.68K derived: sum of 2 quarters · filed 2026-03-31 | -$883.71K derived: sum of 3 quarters · filed 2026-03-31 | -$414.71K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$340.38K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$688.42K derived: sum of 2 quarters · filed 2025-11-20 | -$219.41K 10-Q · filed 2025-11-14 | -$119.41K 10-Q · filed 2024-11-14 | -$393.26K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-06-30 | -$348.04K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | $120.97K 10-Q/A · filed 2025-11-20 | $220.97K 10-Q · filed 2024-09-23 | -$52.88K derived: sum of 3 quarters · filed 2025-11-20 | $203.06K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-03-31 | $469.00K 10-Q · filed 2025-10-15 | $295.15K derived: sum of 2 quarters · filed 2025-10-15 | $551.10K derived: sum of 3 quarters · filed 2025-10-15 | -$222.79K derived: sum of 4 quarters · filed 2025-10-15 | ||
| 2023-12-31 | -$173.85K derived: 10-K/A 12 month − 10-K/A 9 month · filed 2025-08-29 | $82.09K derived: sum of 2 quarters · filed 2025-08-29 | -$691.79K derived: sum of 3 quarters · filed 2025-08-29 | -$104.04K 10-K/A · filed 2025-08-29 | ||
| 2023-09-30 | $255.94K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2025-08-29 | -$517.94K derived: sum of 2 quarters · filed 2025-08-29 | $69.81K 10-K/A · filed 2025-08-29 | $13.56K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$773.88K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2025-08-29 | -$186.13K 10-K/A · filed 2025-08-29 | -$223.63K 10-Q · filed 2024-09-23 | |||
| 2023-03-31 | $587.75K 10-K/A · filed 2025-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |